Pulmonary Thromboembolism - PowerPoint PPT Presentation

1 / 55
About This Presentation
Title:

Pulmonary Thromboembolism

Description:

One clot or many clots that form at distant sites and lodge in the ... 12-year-old FS dachshund. Presented for lethargy, anorexia, tachypnea, and possible CHF. ... – PowerPoint PPT presentation

Number of Views:1464
Avg rating:3.0/5.0
Slides: 56
Provided by: CVM54
Category:

less

Transcript and Presenter's Notes

Title: Pulmonary Thromboembolism


1
Pulmonary Thromboembolism
  • Emily S. Southward DVM
  • University of Missouri Columbia Veterinary
    Medical Teaching Hospital

2
Definition
  • Pulmonary thromboembolism
  • One clot or many clots that form at distant sites
    and lodge in the pulmonary vasculature.
  • Pulmonary artery thrombus
  • Clots that form in the pulmonary vasculature.
  • Clots can partially or fully occlude pulmonary
    vessels.

3
Virchows Triad
  • Venous stasis.
  • Injury or abnormalities to the vessel wall.
  • Alterations in coagulation properties.

4
Venous Stasis
  • Accumlation of activated procoagulants.
  • Immobilization
  • Inadequate cardiac pump.
  • Promotes thrombus formation.

5
Vessel Wall Injury
  • Acute or chronic injury to vessel endothelium.
  • Leads to activation of platelets and clotting
    cascade.
  • Promotes thrombus formation.

6
Vessel Injury
7
Platelet Adhesion
8
Aggregation
9
(No Transcript)
10
Alternations in Coagulation
  • Increase in procoagulant factors.
  • By trauma to vascular wall or extravascular
    tissues.
  • Releases tissue thromboplastin and phospholipid.
  • Leads to formation of prothrombin activator.
  • Prothrombin ? Thrombin

11
Alterations in Coagulation
  • Decrease in anticoagulant factors.
  • Thrombomodulin
  • Antithrombin III
  • Heparin
  • Alpha2-Marcoglobulin
  • Plasmin
  • Leads to hypercoagulable state by formation of
    thrombin.

12
Thrombosis Formation
  • Platelet nidus at site of injury.
  • Growth by aggregation of platelets and fibrin.
  • Activation of clotting cascade.
  • Larger growth to a red fibrin thrombus.
  • Thrombus fractures and embolizes to other areas
    of the body.

13
Predisposing Factors or Diseases for Development
of PTE
  • Hypercoagulable state
  • Nephrotic syndrome
  • Immobilization
  • Amyloidosis
  • Early DIC
  • Hyperadrenocorticism
  • Capillary fragility
  • Activation of clotting cascade.

14
Predisposing Factors or Diseases for Development
of PTE
  • Hypercoagulable state
  • Capillary fragility
  • Diabetes Mellitus
  • Immunemediated hemolyitc anemia
  • Sepsis
  • Hyperadrenocorticism
  • Activation of clotting cascade.

15
Predisposing Factors or Diseases for Development
of PTE
  • Hypercoagulable state
  • Capillary fragility
  • Activation of clotting cascade.
  • Sepsis
  • Pneumonia/pyothorax
  • Heartworm disease
  • Surgery
  • Bacterial endocarditis
  • Neoplasia

16
Consequences of PTE
  • Respiratory.
  • Increased alveolar dead space.
  • Hyperventilation.
  • Hypoxemia.
  • Ventilation/perfusion inequality.
  • Intrapulmonary shunts.

17
Normal Alveolus
18
Increased Alveolar Dead Space
19
Hypoxemia
  • Results from ventilation-perfusion inequality,
    physiologic shunting and increased dead space.

20
Intrapulmonary Shunts
  • Blood that has not been to areas of ventilated
    lung and enters systemic circulation without gas
    exchange taking place.
  • Poorly oxygenated blood enters the arterial
    system lowering the PaO2.
  • Not responsive to oxygen therapy.

21
Ventilation/Perfusion Inequality
  • V/Q inequality occurs when distribution of blood
    is altered to the alveoli.
  • O2 increase in the alveoli and CO2 decreases.

22
Hemodynamic Changes
  • Increase in pulmonary vascular resistance.
  • Increased afterload to the right heart.
  • Can lead to circulatory collapse and shock.

23
Clinical Signs
  • Not pathognomonic.
  • Dyspnea.
  • Tachypnea.
  • Hemoptysis.
  • Tachycardia.
  • Hypoxemia.
  • Sudden death.

24
Diagnosis
  • CBC/Biochemistry results reflect primary disease
    process.
  • Hypoxemia common but 10 of patients are normal.
  • Thoracic radiographs can be normal and
    inconclusive.

25
  • LaRue MJ and Murtaugh RJ. Pulmonary
    Thromboembolism in Dogs47 cases (1986-87). J
    Amer Vet Med Assoc. 1990 Nov. 15197(1)1368-1372.
  • Johnson LR et al. Pulmonary Thromboembolism in 29
    dogs1985-1995 J Vet Intern Med. 1999
    Jul13(4)338-345.
  • Flükiger MA and Gomez JA. Radiographic Findings
    in Dogs with Spontaneous Pulmonary Thrombosis or
    Embolism. Veterinary Radiology, Vol.25,No.3
    124-131.

26
Advanced Diagnostics
  • Pulmonary scintigraphy
  • Pulmonary angiography.

27
Pulmonary Scintigraphy
  • Noninvasive
  • Aids in diagnosis of PTE but not definitive.
  • Two types- ventilation and perfusion scans.

28
Perfusion Scan
  • Performed first.
  • Normal study rules out PTE.
  • Radionuclide-labelled, macroaggregated albumin in
    peripheral vein.

29
Ventilation Scan
  • Inhaled radioactive inert gas-senon-133 or
    technetium-99m.
  • Patient under general anesthesia.
  • Normal in PTE.

30
Ventilation/Perfusion Combo
  • With PTE the ventilation scan would be normal and
    the perfusion scan abnormal.
  • Suggestive of PTE.F
  • Picture from WWW.bschsys.org/DiagnositcImaging/nuc
    md/htm

31
Normal Human Perfusion Scan
32
Abnormal Human Perfusion Scan
33
Pulmonary Angiography
  • Performed if definitive diagnosis or exclusion of
    PTE is required.
  • Requires sedation or general anesthesia.
  • Greater risks.
  • Intraluminal filling defect and sharp cutoff are
    diagnostic for PTE.

34
Pulmonary Embolus
  • Human lung.
  • Arrow indicates abrupt termination of a pulmonary
    artery.
  • Www.brighamrad.Harvard.edu/cases/bwh/images.

35
Treatment
  • Oxygen therapy.
  • Heparinization 200-300 units/kg subcutaneously
    every 8 hours.
  • Streptokinase or TPA.
  • Mechanical ventilation.
  • Long term- warfarin therapy.

36
Monitoring
  • Clotting times- want to maintain PTT at 1.5-2.5
    times normal or and ACT at 1.2-1.4 times normal.
  • Serial arterial blood gas analysis.
  • Respiratory rate.
  • Central venous pressure.
  • All other basic monitoring.

37
Complications Of Therapy
  • Hemorrhage most common.
  • Not predictable.
  • Protamine therapy indicated with hemorrhage due
    to heparin.
  • Vitamin K or fresh-frozen plasma in warfarin
    therapy.

38
Prognosis
  • Guarded.
  • Improves with early detection and treatment.
  • Improves each day the patient survives.
  • At risk for more emboli.

39
UMC VMTH Cases
  • Three in data base.
  • Sadie
  • Magnum
  • Koko

40
Sadie Bailey
  • 8-year-old FS mixed breed dog.
  • Presented for weight loss, anemia, and anorexia.
  • Weak and lethargic on presentation
  • Hemoabdomen, thrombocytopenia, and neutrophilia
    with left shift.
  • Developed severe dyspnea and ventricular
    tachycardia.

41
Sadies Thoracic Films
42
Sadies Thoracic Films
43
Sadies Necropsy
  • Hepatocellular carcinoma
  • Adrenocortical hyperplasia
  • Pulmonary thrombois most lobar branches
    effected.
  • Renal infarction.

44
(No Transcript)
45
Magnum Meeks
  • 8-year-old MC doberman pinscher
  • Presented for dyspnea of two days duration.
  • Protein losing nephropathy.

46
Magnums Thoracic Films
47
Magnums Thoracic Films
48
Koko Westerhoff
  • 12-year-old FS dachshund.
  • Presented for lethargy, anorexia, tachypnea, and
    possible CHF.
  • History includes diabetes mellitus, IVDD and
    cataracts.
  • PE- Increased BV lung sounds, mild crackles,
    tachycardia, and left systolic murmur.

49
Kokos Thoracic Films
50
Kokos Thoracic Films
51
Kokos Pefusion Scintigraphy
52
Kokos Pefusion Scintigraphy
53
Kokos Necropsy
  • Muliple small thrombi in the pulmonary
    vasculature.
  • Cardiomegaly

54
Thanks
  • Dr. Mann
  • Dr. Dodam
  • Dr. Lattimer
  • Dr. Kunz

55
Questions?
Write a Comment
User Comments (0)
About PowerShow.com